|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/5575 | |
| A61P 27/02 |
| (11) | Patento numeris | 2802331 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13700826.4 |
| Europos patento paraiškos padavimo data | 2013-01-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-11-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-12-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/021023 |
| Data | 2013-01-10 |
| (87) | Numeris | WO 2013/106565 |
| Data | 2013-07-18 |
| (30) | Numeris | Data | Šalis |
| 201261584877 P | 2012-01-10 | US | |
| 201261611920 P | 2012-03-16 | US |
| (72) |
AHLUWALIA, Gurpreet, US
WHITCUP, Scott M., US
BEDDINGFIELD, Frederick C., US
EDWARDS, Sydney G., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | TOPICAL TREATMENT FOR CHEMOTHERAPY INDUCED EYELASH LOSS OR HYPOTRICHOSIS USING PROSTAMIDE F2 ALPHA AGONISTS |
| TOPICAL TREATMENT FOR CHEMOTHERAPY INDUCED EYELASH LOSS OR HYPOTRICHOSIS USING PROSTAMIDE F2 ALPHA AGONISTS |